Patent Ductus Arteriosus

Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

HeartR™ PDA Occluder Post-Market Follow-Up Study

PDA for Kidneys Study

Management of the PDA Trial

Improving Care for Children With Congenital Heart Disease.

Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus

NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot

Ibuprofen vs Expectant Management for hsPDA in Preterm Infants: Retrospective Cohort

The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease

Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

Amplatzer Piccolo Occluder Japan Post-marketing Database Surveillance

Precision Dosing of Oral Ibuprofen for PDA, A Pilot RCT

Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus

AMPLATZER Duct Occluder II Additional Sizes

Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus

Canadian National PDA Treatment Study

Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus

Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates

Preliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight Infants

Radiation-Free Heart Catheterization Using MRI